Brief: Artiva Biotherapeutics Announces Pricing Of $300 Million Underwritten Offering Of Common Stock And Pre-Funded Warrants
08/05/2026 12:08
May 8 (Reuters) - Artiva Biotherapeutics Inc ARTV.O: ARTIVA BIOTHERAPEUTICS ANNOUNCES PRICING OF $300 MILLION UNDERWRITTEN OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS ARTIVA BIOTHERAPEUTICS INC - PRICES OFFERING OF 23.9 MILLION SHARES AT $11.52 PER SHARE AND 2.2 MILLION PRE-FUNDED WARRANTS AT $11.5199 PER SHARE Source text: ID:nGNX9ThdkQ Further company coverage: ARTV.O ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Artiva Biotherapeutics
See all newsBrief: Artiva Biotherapeutics Provides Update On Planned Allonk® Data Disclosures And Development Milestones For The Remainder Of 2026
Artiva Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Artiva Biotherapeutics Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Artiva Biotherapeutics Inc Thad Huston To Separate As CFO Effective May 22, 2026
U.S. STOCKS ON THE MOVE-Corning, BILL Holdings, Moderna